Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.150
+0.050 (4.55%)
At close: Nov 20, 2024, 4:00 PM
1.140
-0.010 (-0.87%)
After-hours: Nov 20, 2024, 7:59 PM EST
Artelo Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 |
| Selling, General & Admin | 3.9 | 4.23 | 5.96 | 6.29 | 4.6 | 2.77 | |
| Research & Development | 5.64 | 5.7 | 4.32 | 5.83 | 2.84 | 1.92 | |
| Operating Expenses | 9.54 | 9.93 | 10.29 | 12.13 | 7.44 | 4.69 | |
| Operating Income | -9.54 | -9.93 | -10.29 | -12.13 | -7.44 | -4.69 | |
| Interest Expense | - | - | -0.01 | - | - | - | |
| Interest & Investment Income | - | - | 0 | 0 | 0 | 0 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.03 | |
| EBT Excluding Unusual Items | -9.54 | -9.93 | -10.29 | -12.12 | -7.44 | -4.66 | |
| Gain (Loss) on Sale of Investments | 0.42 | 0.64 | 0.21 | 0.02 | 0 | - | |
| Pretax Income | -9.12 | -9.29 | -10.08 | -12.11 | -7.44 | -4.66 | |
| Net Income | -9.12 | -9.29 | -10.08 | -12.11 | -7.44 | -4.66 | |
| Net Income to Common | -9.12 | -9.29 | -10.08 | -12.11 | -7.44 | -4.66 | |
| Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 1 | 0 | |
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 1 | 0 | |
| Shares Change (YoY) | 11.52% | 4.48% | 27.04% | 79.12% | 403.69% | 70.67% | |
| EPS (Basic) | -2.85 | -3.14 | -3.56 | -5.43 | -5.97 | -18.83 | |
| EPS (Diluted) | -2.85 | -3.14 | -3.56 | -5.43 | -5.97 | -18.83 | |
| Free Cash Flow | -8.38 | -8.21 | -8.01 | -8 | -6.14 | -4.35 | |
| Free Cash Flow Per Share | -2.61 | -2.77 | -2.83 | -3.59 | -4.93 | -17.59 | |
| EBITDA | - | - | - | - | -7.44 | -4.69 | |
| D&A For EBITDA | - | - | - | - | 0 | 0 | |
| EBIT | -9.54 | -9.93 | -10.29 | -12.13 | -7.44 | -4.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.